Plain-English translation of NCT05884775 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new digital tool called iMatter2 that uses artificial intelligence to help you manage your type 2 diabetes. The app works alongside your doctor's care and may help you keep better track of your blood sugar and make healthier decisions. Researchers want to see if using this tool for 12 months helps lower your blood sugar levels more than standard care alone.
Many people with type 2 diabetes struggle to keep their blood sugar under control with regular doctor visits alone. This study exists to find out whether a personalized, AI-powered app that sends you text messages and tracks your progress can help you manage your diabetes more effectively.
You likely qualify if…
You likely don't qualify if…
If you're chosen for the study, you'll either receive the new iMatter2 app to use for 12 months, or you'll continue with your regular diabetes care (the comparison group). If you get the app, you'll use it to track your health information and receive personalized text message reminders and tips. Your doctor will also use the app to see how you're doing. Throughout the year, researchers will check your blood sugar levels to see if the app helps you manage your diabetes better.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States
Sponsor
NYU Langone Health
Enrollment target
~353 participants
Started
November 2025
Primary completion
March 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Priscilla D'antico
NYU Langone Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.